/PRNewswire/ -- Orexo US, Inc. (Orexo) announced that following U.S. Food and Drug Administration (FDA) approval, the new 8.6mg/2.1mg dosage strength of ZUBSOLV ® is now available . This approval is based on the supplemental New Drug Application ... Pink Sheets, 3 weeks ago
Orexo US launches new 8.6/2.1 mg ZUBSOLV® (buprenorphine/naloxone) sublingual tablet CIII: 8.6/2.1mg - TickerTech.com, 3 weeks ago
1 images for "Suboxone Tablets"
INTRODUCTIONOral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets / capsules to modern-day fast disintegrating and rapidly acting tablets / films, the market has come a long way. Lower ...Individual.com, 2 months ago
Determination That SUBUTEX (Buprenorphine Hydrochloride) Sublingual Tablets, Equivalent 2 Milligrams Base and Equivalent 8 Milligrams Base, Were Not...
Determination That SUBUTEX (Buprenorphine Hydrochloride) Sublingual Tablets, Equivalent 2 Milligrams Base and Equivalent 8 Milligrams Base, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness Notice. Citation: "80 FR 8088" ...Pharmacy Choice, 1 month ago
Indivior's net revenues fell by 8% to $1,115m in the year to the end of December reflecting increased generic tablet and branded (tablet and buccal patch) competition to Suboxone Film in the US and price cuts in Europe due to governmental ...TrustNet, 1 month ago
Michael Higgins of Highline Research Advisors believes it is absolutely vital for a sellside biotech analyst to understand what's going on outside the sector, because no stock lives on an island. The most fabulous fundamentals in the world won't ...Equities.com, 2 weeks ago How to Beat the Herd Mentality: Highline's Michael Higgins BioMedReports, 1 month ago
Americans want access to inexpensive pharmaceutical drugs. This demand must be balanced with the fact that brand-name, innovator pharmaceutical companies typically invest tremendous resources to research and develop new drugs, bring them to market ...JD Supra, 3 weeks ago
Operator Ladies and gentlemen, thank you for standing by. And welcome to the Insys Therapeutics Fourth Quarter Year End 2014 Results Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a ...Seeking Alpha, 3 weeks ago Insys announces plans to submit NDA to FDA for treatment of CINV Individual.com, 2 months ago INSYS THERAPEUTICS : to Initiate Five Phase III Clinical Trials in 2015 4 Traders, 2 months ago INSYS Therapeutics To Initiate Five Phase 3 Clinical Trials In 2015 1/13/2015 ClinicSpace, 2 months ago
Michele Braa-Heidner started taking prescription painkillers when she had her wisdom teeth removed. Soon after, she developed a painful spinal condition for which she needed several surgeries--and more medications. The drugs relieved the pain and ...Jewish World Review, 4 weeks ago
Posted on 24th February 2015 An Ilkeston man has been sentenced to four and a half years in prison for drug offences. Neil Fowkes, 54, of Cotmanhay Road Ilkeston was sentenced at Derby Crown Court on Friday, February 20 ...Derbyshire Constabulary, 1 month ago
A CVS pharmacy technician is awaiting trial after she allegedly stole prescription narcotics and testosterone for a man she claims was threatening her and her children, according to MassLive.com. Kesha Germaine, 27, of Springfield, Massachusetts, ...Pharmacy Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!